在GLA中的新一类致病性非编码变异.
Yujing Yuan1, Xinyu Zhang1, Chen Ling1
1Department of Neurology, Peking University First Hospital, Beijing 100034, China.
International journal of molecular sciences
|January 28, 2026
概括
长读测序 (LRS) 在两名法布里病 (FD) 患者中发现了新的非编码变异,揭示了这种疾病的新遗传原因. 这种先进的技术有助于诊断传统遗传检测未能诊断的复杂病例.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 费布里病 (FD) 呈现出多样化的临床症状,使得诊断具有挑战性,特别是非经典形式.
- 对α-银酸酶A (GLA) 基因的基因测试对于FD诊断和遗传咨询至关重要.
- 像桑格测序和短读下一代测序 (NGS) 这样的传统方法可以错过深层内在,复杂或大的变异.
研究的目的:
- 调查长读序列 (LRS) 在诊断具有传统遗传检测负结果的FD病例中的实用性.
- 识别导致FD的新型遗传变异,这些变异在患者中具有无法解释的临床表现.
- 为了证明LRS在检测标准测序技术遗漏的变异方面的能力.
主要方法:
- 涉及两个无关的男性患者的案例系列,具有FD的临床,酶和病理特征.
- 使用桑格测序和NGS对GLA基因中的致病变体进行初始遗传测试.
- 应用LRS以实现内在和重复区域的全面覆盖.
- RNA测序和定量实时PCR用于分析基因表达和转录变异.
主要成果:
- 在这两名患者中,LRS发现了新的非编码变异,这些变异在桑格测序和NGS中错过了.
- 患者1在内子4 (LINE-1元素) 中进行了~1.7kb的插入,从而产生了两个新的GLA转录.
- 患者2在5'-未翻译区域 (SINE-VNTR-Alu元素) 存在约2.5kb的插入,导致正常GLA转录表达的减少.
结论:
- 非编码变体,特别是重复元素中的插入,可以解释FD以前未知的遗传原因.
- LRS是诊断具有异常或复杂遗传基础的FD病例的强大工具.
- 这项研究强调了探索内基和非编码区域对于FD的完整遗传诊断的重要性,并建议LRS用于未解决的病例.
更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.5K
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.3K
相关概念视频
02:30Histone Variants at the Centromere
5.0K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.0K
02:39lncRNA - Long Non-coding RNAs
9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
02:39lncRNA - Long Non-coding RNAs
3.6K
3.6K
01:29Nursing Code of Ethics
4.5K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.5K
01:25Drug Classes and Categories
3.1K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.1K
01:25Antibody Structure and Classes
9.1K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.1K